Novo Nordisk's REDEFINE trials test CagriSema for weight and heart health in adults with type 2 diabetes and/or obesity. Participate and shape diabetes care.

Uncover the complex link between obesity, asthma, and diabetes, plus effective management strategies to deal with allergens during peak allergy season.

Novo Nordisk's Wegovy cuts heart risk by 20% in people with obesity or overweight and without diabetes. Semaglutide's potential reshapes cardiovascular & obesity...

Lilly’s SURMOUNT-3 and SURMOUNT-4 clinical trials show that Mounjaro (tirzepatide) demonstrates remarkable weight loss in patients with a BMI of more than 30, with...

Learn about the importance of Ozempic – the new “miracle” diet drug that celebrities are using for weight loss – in diabetes care and weight loss while challenging...

The debate over how many carbohydrates people should consume has raged for decades. Experts share their perspectives on low, very low, and moderate carb diets for ideal...

Obesity management options include lifestyle changes, medication, and surgery. Here's what you need to know to make informed decisions about what treatments are optimal...

Looking for natural ways to help lower your blood sugar? Try exercise, fiber supplements, apple cider vinegar, fenugreek, zinc, and probiotic foods. Always consult with...

Uncover phase 2 clinical trial results of CagriSema, a promising diabetes treatment showing improvements in A1C, weight loss, and time in range.

Pfizer propels clinical trials for danuglipron, a novel oral GLP-1 medication for obesity and type 2 diabetes, with promising preliminary results for A1C and weight loss.

At the 17th annual Diabetes Forum at ADA 2023, the diaTribe Foundation and TCOYD moderated an expert panel that discussed access and equity issues, breakthrough...

Clinical trial participants taking retatrutide for obesity experienced an average of 24% in body weight reduction over 48 weeks. Lead scientists shared their findings at...

Results from a recent clinical trial showed the new medication survodutide may be a useful treatment tool for weight loss. People with overweight or obesity on the...

end Uncover SURMOUNT-2 trial's outcomes: Tirzepatide's promise for weight loss, better blood sugar, and improved cardiometabolic health in type 2 diabetes.

New findings from the DiRECT trial reveal that weight loss can lead to type 2 diabetes remission. Learn about the benefits of a low-calorie diet and support in diabetes...

FDA warns people to avoid using some forms of compounded substitutes of semaglutides that lack the safety and efficacy of popular weight loss drugs Wegovy, Ozempic, and...

In case you missed them, here are our top stories from May 2023. This month’s best stories cover a wide variety of topics like upcoming therapies, new research findings...

Early findings from a phase 3 clinical trial demonstrated that participants treated with 50 mg oral semaglutide achieved a remarkable weight loss of 17.4%. This research...

Struggling with body positivity, overweight, and diabetes can be overwhelming. But it's possible to balance all three and improve your overall well-being.

Learn 4 tips to help you prevent GDM, such as eating a balanced diet, exercising regularly, and monitoring your blood sugar levels.